cis-Docos-13-enylamine

Compound 9
To a solution of LAH (2.30 g, 29.6 mmol) in dry THF (100 mL) was added a solution of cis-docosenoamide (6) (10.0 g, 29.7 mmol) in dry THF (100 mL) and refluxed. After 12 h the reaction mixture was cooled and Na 2 SO 4 ·10H 2 O was added slowly until the reaction ceased. The solution was filtered and concentrated in vacuo to afford cis-docos-13-enylamine (9) (9.55 g, 29.6 mmol, quant.) as a pale yellow oil.
R f = 0.41 (methanol/pyridine/triethylamine 4:4:1). 9H-fluoren-9-ylmethyl (13Z)-docos-13-en-1-ylcarbamate
IR (ATR)

S7
Compound 10
cis-Docos-13-enylamine (9) (1.00 g, 3.10 mmol) was dissolved in 1,4-dioxane (40 mL) and a saturated solution of NaHCO 3 in water (20 mL) was added. 
9H-fluoren-9-ylmethyl (13-oxotridecyl)carbamate Compound 5
At -78 °C, ozone (made from oxygen 4.0) was bubbled through a solution of 10 (1.50 g, 2.75 mmol) in dry DCM (50 mL) until the characteristic blue color could be observed.
After argon was bubbled through the solution for 30 min, zinc powder (3.50 g, 53.5 mmol) and acetic acid (4.00 mL, 70 mmol) was added and the solution was allowed to warm up to 10 °C. After 30 min, the solution was filtered, washed with water (50 mL) and a S8 saturated solution of NaHCO 3 in water (50 mL). 
9H-fluoren-9-ylmethyl (13-hydroxyhexadec-15-en-1-yl)carbamate Compound 11
A solution of AllylMgCl (1.19 mL, 1.6 M in THF) was added at 0 °C to a solution of (R,R)-Duthaler-Hafner reagent (1.37 g, 2.24 mmol) in dry and degassed Et 2 O (30 mL).
Stirring was continued for 1 h at 0 °C and then the solution was allowed to warm up to rt and stirred for additional 3 h. After cooling to -78 °C, aldehyde 10 (750 mg, 1.72 mmol)
was added and the reaction was stirred at -78 °C for 4 h. Water (20 mL) was added and stirring was continued for 12 h at room temperature. A saturated aqueous solution of NH 4 Cl (20 mL) was added and the mixture was extracted three times with DCM (40 mL each Mosher Analysis:
Racemate of compound 11 was synthesized by using the zinc-mediated aqueous
Barbier-Grignard reaction [2] . Mosher ester of the racemate and the title compound was synthesized by Steglich esterification with R-α-methoxy-α-(trifluoromethyl)phenylacetic acid [3] . NMR analysis at 600 MHz show split signals at 5.80-5.71 and 5.67-5.59 ppm.
Integration of these signals gave 94%ee. 
Di-tert-butyl [(E)-{[13-(methoxymethoxy)hexadec-15-en-1-yl]amino}methylylidene]biscarbamate Compound 12
MOMCl (270 µL, 3.56 mmol, 5 equiv) was added at 0 °C to a solution of alcohol 11
(566 mg, 1.19 mmol) and DIPEA (809 µL, 4.76 mmol, 4 equiv) in dry DCM (30 mL).
Stirring was continued for 1 h at 0 °C and then the solution was allowed to warm up to rt S10 and stirred for an additional 12 h. Water (20 mL) was added and stirring was continued for 1 h at room temperature. The mixture was extracted three times with DCM (40 mL each). After drying the combined organic layers over Na 2 SO 4 the solvent was removed in vacuo.
The brown oil was dissolved in DCM (30 mL), piperidine (6 mL) was added and the mixture was stirred for 12 h at room temperature. The solid was removed by filtration and the filtrate was concentrated in vacuo until 20 mL of DCM were left. The mixture was filtered again and the solvent was removed completely in vacuo.
The residue was dissolved in dry DCM ( 
15-[N',N''-Bis(tert-butoxycarbonyl)carbamimidamido]-3-(methoxymethoxy)pentadecanoic acid
S12
S13
Cbz-L-Thr(OH)-D-allo-Ile-L-Tyr(OH)-D-allo-Thr(OH)-D-Gln-Allyl Compound 27
Linear peptide 27 was synthesized on a 0.6 mmol scale on a Tentagel R RAM resin using the SPPS protocol described above. Sample cleavage was done with a mixture of TFA, TIS and water (95:2.5:2.5; 30 mL/mmol) for 3 h. Triple coevaporation with toluene gave the crude peptide (5 mg) which was analyzed by HPLC-MS. Additionally, the crude peptide was purified with preparative HPLC (isocratic 30% A) to yield 4 mg of the pure Peptide which was analyzed by NMR spectroscopy. 1-hydroxyethyl]-3,19-dimethyl-2,5,8,11,14,17-hexaoxo-1-oxa-4,7,10,13,16-pentaazacyclononadecan-18-yl}amino) Cyclodepsipeptide 19 (19 mg, 23.4 µmol) was dissolved in DMF (8 mL) and palladium on charcoal (2 mg, 10 wt % Pd on carbon) was added. After stirring for 12 h under hydrogen atmosphere (1 bar), the mixture was filtered and the solvent was removed in vacuo to yield the amine (16 mg).
Di-tert-butyl [(E)-{[(13R)-15-({(3R,6R,9R,12S,15R,18S,19R)-6-(3-amino-3-oxopropyl)-15-[(2S)-butan-2-yl]-12-(4-hydroxybenzyl)-9-[(1R)-
Protected GHPD acid 3 (21.7 mg, 38.8 µmol, 2 equiv) was dissolved in DMF (2 mL), HATU (13.9 mg, 36.6 mmol, 1.9 equiv) and NMM (16.0 µL, µmol, 7.6 equiv) were added and the mixture was stirred for 5 min. After this time span, amine (13.0 mg, 19.2 µmol) was added and the mixture was stirred for 70 h at room temperature. Removal of the solvent in vacuo and purification by preparative HPLC (ACE C18 60% A for 4 min, then gradient to 90% A in 10 min) yielded pure cyclodepsipeptide 24 (3.8 mg, 3.12 µmol, 16%). 
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